Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MDLN · against 62 other Healthcare companies of similar size
Ranked #4 of 63 · scores higher than 95% of peers
Bars: peers in each 10-point band of the valuation score5 peers with a valuation score of 80–89, including MDLN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | MDLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 60 reported | 2.3% | 3.0% | 36% | 30% | |
| EBITDA yieldHigher is better · 64 reported | 5.3% | 6.1% | 44% | 50% | |
| Free cash flow yieldHigher is better · 46 reported | Not reported | 3.6% | — | — | 20% |
| Book yieldHigher is better · 59 reported | 38.7% | 21.4% | 71% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 4 | 45.9B USD | 84 | 61 | |
| 5 | 34.3B USD | 83 | 57 | |
| 6 | 23.8B USD | 82 | 84 | |
| 7 | 3.53T JPY (≈$24.0B) | 78 | 68 | |
| 8 | 89.7B USD | 76 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score